Abstract

The study has been conducted in Animal House/Faculty of Sciences/University of Kufa between December 2022 and February 2022, fifteen female Albino Rats are used. Gentamicin is aminoglycoside antibiotics widely used during pregnancy for treatment the infections. The present study has been intended to show Alfa Feto Protein parameter in serum and the histological effects of gentamicin on pups liver by SEM in female Albino Rats. The females Rats are randomly divided into three main groups, comprising five rats for each group .The control group is given inta peritoneal injection of physiological normal saline and the second and third group are given inta peritoneal injection of gentamicin doses twenty, forty mg/kg/day respectively for 20 days from the first day to the end of experimental allocated for each female.The rats are sacrificed in 20 th (dpc) to study the Alfa Feto Protein parameter in serum and histological effects of gentamicin on pups liver. The physiological study show negative results in all study groups due to absent of malformations in pups and present histological effects in external architecture structure of pups liver compare with control groups. In conclusion; aminoglycoside gentamicin caused histological effects on pupa liver and not absent of malformations in pups due to negative results of Alfa Feto Protein parameter.

Details

Title
A study of Alfa Feto Protein parameter in Serum and Histological Effects of Pups Liver by SEM in Pregnant Rats Exposed to Overdose of Aminoglycoside antibiotics
Author
Ali, Ashraf Raoof Mohammed 1 ; Abdul-Zahra, Noor I 2 ; Kadhim, Doaa Amer 3 

 Vacuity of Sciences, University of Kufa, Najaf, Iraq 
 AI-Furat Al-Awsat Technical University, Iraq 
 Faculty of Sciences, University of Kufa, Najaf , Iraq 
Pages
48-52
Section
ORIGINAL RESEARCH
Publication year
2023
Publication date
Aug 2023
Publisher
Russian New University
e-ISSN
23047232
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2894465888
Copyright
© 2023. This work is published under http://www.cardiometry.net/issues (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.